FilingReader Intelligence
IOL Chemicals plans UK subsidiary, minoxidil expansion
August 7, 2025 at 09:10 AM UTC•By FilingReader AI
IOL Chemicals & Pharmaceuticals announced the formation of a wholly-owned subsidiary in the United Kingdom to enhance its global business and customer presence in the UK and EU.
The company also disclosed plans to establish Unit 9B for minoxidil and its intermediates production, with an installed capacity of 120 MTPA. This project, costing INR 5.50 crore, is expected to be completed by December 2025 and will be funded through internal accruals.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
BSE:IOLCP•Bombay Stock Exchange
News Alerts
Get instant email alerts when IOL Chemicals & Pharmaceuticals publishes news
Free account required • Unsubscribe anytime